Novartis raises the sales bar for key cancer drugs, tweaks yearly growth guidancenews2025-11-20T11:43:02+00:00November 20th, 2025|Endpoints News|
Innovent to seek China approval of high-dose obesity shot after Phase 3 hitnews2025-11-20T11:30:31+00:00November 20th, 2025|Endpoints News|
Ensoma halves workforce as genetic medicines startup enters clinicnews2025-11-19T20:52:55+00:00November 19th, 2025|Endpoints News|
PBMs, FTC clash in court over agency’s in-house insulin challengenews2025-11-19T20:45:14+00:00November 19th, 2025|Endpoints News|
Flagship’s Tessera to start first human trial using new gene writing platformnews2025-11-19T20:38:49+00:00November 19th, 2025|Endpoints News|
Lab testing startup Function Health raises $298M Series Bnews2025-11-19T20:30:22+00:00November 19th, 2025|Endpoints News|
FDA approves Bayer’s HER2-mutated lung cancer drugnews2025-11-19T20:28:57+00:00November 19th, 2025|Endpoints News|
Pfizer CFO says drugmaker will ‘supplement’ Metsera deal as part of broader obesity ambitionsnews2025-11-19T19:27:38+00:00November 19th, 2025|Endpoints News|
New tuberculosis treatment shows potential in a Phase 2 studynews2025-11-19T19:05:40+00:00November 19th, 2025|Endpoints News|
Life sciences sector ‘has lost confidence’ in the UK, committee member saysnews2025-11-19T18:59:22+00:00November 19th, 2025|Endpoints News|
